Refine by
Cardiac Patient Articles & Analysis
80 news found
MADRID, Spain – March 2026 – Corify Care announces ATENEA, a project introducing real-time Digital Twin technology to the electrophysiology laboratory, enabling clinicians to simulate and optimize ablation strategies before intervention.ATENEA represents Phase 2 of the Corify platform, focusing on AI-driven Digital Twin development to assist electrophysiologists in diagnosing and treating complex ...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. ...
The study adds to the evidence obtained in the randomized controlled ROCKET-AF study and supports the use of Xarelto in this patient group, including the cautious use for patients with CKD stage 4 (the use of Xarelto is not recommended in patients with creatinine clearance < 15 ml/min). ...
ByBayer AG
“We look forward to Amit’s leadership and insights, generated from his deep experience across many sectors of healthcare, spanning both patient-centric and clinician-facing digital health chronic disease ...
Since the IDMC authorization, three patients have been dosed in the Phase 2 expansion cohort. This progress highlights the potential for gene therapy to go beyond rare diseases and to address larger patient populations with significant unmet needs, such as chronic cardiovascular diseases. ...
When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. gammaCore (nVNS) is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated ...
“Through our collaboration with Osso VR, we’re providing a powerful learning environment that will democratize access to advanced education and allow care providers to flourish in their field, bringing leading-edge cardiac procedures to more patients.” The ACC is one of a number of healthcare organizations utilizing Osso VR’s ...
(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...
When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. gammaCore (nVNS) is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated ...
When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. gammaCore (nVNS) is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated ...
Cardiac arrhythmias affect not only adults, but unfortunately also children struggle with such health problems. It is for little patients that the K.I.D.S. Foundation announced a competition "Telemedicine in Children's Hospitals of the Future". ...
Results from the device’s first-in-human study were published on September 17, 2022 and showed 100% procedural success in four patients. In addition, cardiac output increased by 25%, urine output increased by nine-fold, and left ventricular end-diastolic pressure decreased by 78%. ...
Yet, the barriers to care are high with only 11% of patients who have OUD receiving the MOUD they need.2 Additionally, OUD relapse is common amongst patients. ...
(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...
“During our clinical study using the Bodyport Cardiac Scale, we found patients more engaged, and our clinical team better empowered to make timely, individualized treatment adjustments to get ahead of changes in a patient’s condition before they worsen. ...
Medgadget: How does the Cardiac Scale fit with a patient’s daily life? John Lipman: Patients need only spend approximately 20 seconds on a very familiar morning activity – stepping onto a scale. The Bodyport solution is designed to capture hemodynamic signals through the Cardiac Scale to power optimized interventions ...
rst-in-human study to evaluate the performance of its ModulHeart percutaneous heart pump designed to reduce cardiac afterload and improve renal perfusion in patients with advanced heart failure (HF). Four patients had ModulHeart deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention (PCI) ...
Most recently, he was President and CEO of Keystone Heart, a structural heart medical device company, and creator of the first Cerebral Embolic Protection device designed to provide complete coverage to all brain regions for patients undergoing cardiac procedures. Keystone Heart was acquired in 2018 by Venus Medtech, the leader in transcatheter structural heart ...
BySafeHeal
When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. gammaCore (nVNS) is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated ...
“Patients with refractory angina have no treatment options, and the results from the Phase 1 portion of the EXACT trial suggest a dose response and therapeutic potential which is encouraging for the development of XC001 as a treatment to improve these patients’ quality of life. ...